Author
Listed:
- Yu Mi Oh
(Seoul National University College of Medicine
Seoul National University College of Medicine, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Korea
Specific Organs Cancer Branch, Research Institute National Cancer Center)
- Hyung Bae Park
(Seoul National University College of Medicine
Seoul National University College of Medicine, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Korea
Hematologic Malignancy Branch, Research Institute National Cancer Center)
- Jae Hun Shin
(Specific Organs Cancer Branch, Research Institute National Cancer Center
Present address: Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.)
- Ji Eun Lee
(Seoul National University College of Medicine
Seoul National University College of Medicine, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Korea
Specific Organs Cancer Branch, Research Institute National Cancer Center)
- Ha Young Park
(Seoul National University College of Medicine
Seoul National University College of Medicine, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Korea)
- Dhong Hyo Kho
(Specific Organs Cancer Branch, Research Institute National Cancer Center
Present address: Department of Pathology and Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.)
- Jun Sung Lee
(Specific Organs Cancer Branch, Research Institute National Cancer Center
Present address: Green Cross Corporation, Gyeonggi-Do 446-850, Korea.)
- Heonsik Choi
(Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Present address: Kolon life science inc., Seoul 153-769, Korea.)
- Tomohiko Okuda
(National Cerebral and Cardiovascular Center)
- Koichi Kokame
(National Cerebral and Cardiovascular Center)
- Toshiyuki Miyata
(National Cerebral and Cardiovascular Center)
- In-Hoo Kim
(Molecular Imaging and Therapy Branch, Research Institute National Cancer Center)
- Seung Hoon Lee
(Specific Organs Cancer Branch, Research Institute National Cancer Center)
- Ronald H. Schwartz
(Laboratory of Cellular and Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health)
- Kyungho Choi
(Seoul National University College of Medicine
Seoul National University College of Medicine, 103 Daehak-ro, Chongno-gu, Seoul 110-799, Korea
Specific Organs Cancer Branch, Research Institute National Cancer Center)
Abstract
Induction of T-cell clonal anergy involves serial activation of transcription factors, including NFAT and Egr2/3. However, downstream effector mechanisms of these transcription factors are not fully understood yet. Here we identify Ndrg1 as an anergy factor induced by Egr2. Ndrg1 is upregulated by anergic signalling and maintained at high levels in resting anergic T cells. Overexpression of Ndrg1 mimics the anergic state and knockout of the gene prevents anergy induction. Interestingly, Ndrg1 is phosphorylated and degraded by CD28 signalling in a proteasome-dependent manner, explaining the costimulation dependence of anergy prevention. Similarly, IL-2 treatment of anergic T cells, under conditions that lead to the reversal of anergy, also induces Ndrg1 phosphorylation and degradation. Finally, older Ndrg1-deficient mice show T-cell hyperresponsiveness and Ndrg1-deficient T cells aggravate inducible autoimmune inflammation. Thus, Ndrg1 contributes to the maintenance of clonal anergy and inhibition of T-cell-mediated inflammation.
Suggested Citation
Yu Mi Oh & Hyung Bae Park & Jae Hun Shin & Ji Eun Lee & Ha Young Park & Dhong Hyo Kho & Jun Sung Lee & Heonsik Choi & Tomohiko Okuda & Koichi Kokame & Toshiyuki Miyata & In-Hoo Kim & Seung Hoon Lee & , 2015.
"Ndrg1 is a T-cell clonal anergy factor negatively regulated by CD28 costimulation and interleukin-2,"
Nature Communications, Nature, vol. 6(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9698
DOI: 10.1038/ncomms9698
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9698. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.